Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma
Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma
Recruiting · NCT06552559 · Registry updated 2026-04-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma | B-cell Lymphoma Recurrent; B-cell Lymphoma Refractory; CNS Metastases | Recruiting | Phase 1 / Phase 2 | 2026-04-23 | NCT06552559 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Korean Society of Hematology | 3 |
| Samsung Medical Center | 207 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Samsung Cancer Research Institute | Seoul | South Korea | 1 |
| Samsung Medical Center | Seoul | South Korea | 21 |